57 results on '"Staubach P"'
Search Results
2. Efficacy and safety of apremilast in patients with moderate-to-severe genital psoriasis: Results from DISCREET, a phase 3 randomized, double-blind, placebo-controlled trial.
3. High-dose short-term administration of naringin did not alter talinolol pharmacokinetics in humans
4. Effect of single-dose and short-term administration of quercetin on the pharmacokinetics of talinolol in humans – Implications for the evaluation of transporter-mediated flavonoid–drug interactions
5. 52654 Reaching high treatment goals is linked with a high quality of life in psoriasis patients; 1-year data from the German VALUE study.
6. 52251 Remibrutinib reduces CSU symptoms and rescue medication use in patients with chronic spontaneous urticaria despite absence of background medication.
7. 51362 Overall effectiveness of Risankizumab in special areas and the impact on quality of life; 1-year real world data from the German cohort of the VALUE study.
8. South-north and radial traverses through the interplanetary dust cloud
9. GARADACIMAB PROTECTS AGAINST HEREDITARY ANGIOEDEMA ATTACKS FROM WEEK 1 IN PIVOTAL PHASE 3 VANGUARD STUDY.
10. Long-term transesophageal echocardiography follow-up after percutaneous left atrial appendage closure.
11. Influence of relative acceleration in saturated sand: Analytical approach and simulation of vibratory pile driving tests.
12. Impact of Nurse-Led Interprofessional Rounding on Patient Experience.
13. Off-target phenotypes in forensic DNA phenotyping and biogeographic ancestry inference: A resource.
14. Benefits of a family-centered approach to pediatric induction of anesthesia.
15. Chronic urticaria in children can be controlled effectively with updosing second-generation antihistamines.
16. Omalizumab treatment in patients with chronic inducible urticaria: A systematic review of published evidence.
17. Leadership Development and Interprofessional Nurse-Led Bedside Rounding Improves Nurse Leadership Self-Efficacy.
18. 40665 Efficacy of Apremilast in Patients With Moderate-to-Severe Genital Psoriasis: Body Surface Area Subgroup Results From the Phase 3 DISCREET Trial.
19. Contrasting seasonality of African swine fever outbreaks and its drivers.
20. 34320 Bimekizumab efficacy in subgroups defined by prior systemic treatment in patients with moderate to severe plaque psoriasis.
21. An open-label, proof-of-concept study of lirentelimab for antihistamine-resistant chronic spontaneous and inducible urticaria.
22. Omalizumab in patients with symptomatic chronic idiopathic/spontaneous urticaria despite standard combination therapy.
23. Risk of laryngeal edema and facial swellings after tooth extraction in patients with hereditary angioedema with and without prophylaxis with C1 inhibitor concentrate: a retrospective study.
24. Patent Foramen Ovale Closure With the SeptRx Device: Initial Experience With the First “In-Tunnel” Device.
25. A randomized trial of quilizumab in adults with refractory chronic spontaneous urticaria.
26. Hereditary angioedema caused by missense mutations in the factor XII gene: Clinical features, trigger factors, and therapy.
27. Ligelizumab for adolescent patients with CSU: first results from a dedicated Phase 2b study.
28. Inference of recent admixture using genotype data.
29. Reply to "Comment on: 'Children with chronic urticaria can be effectively controlled with updosing second-generation antihistamines'".
30. Investigation of three sophisticated constitutive soil models: From numerical formulations to element tests and the analysis of vibratory pile driving tests.
31. P152 CLINICAL ACTIVITY OF AK002, AN ANTI-SIGLEC-8 ANTIBODY, IN MULTIPLE FORMS OF UNCONTROLLED CHRONIC URTICARIA.
32. Back-analysis of model tests on piles in sand subjected to long-term lateral cyclic loading: Impact of the pile installation and application of the HCA model.
33. 18078 Evaluation of the efficacy of an exfoliating cleanser and urea-containing cream on keratosis pilaris using clinical and 3D image-based analysis.
34. Impact of the installation on the long-term cyclic behaviour of piles in sand: A numerical study.
35. Long-term deformations of monopile foundations for offshore wind turbines studied with a high-cycle accumulation model.
36. Clinical Activity of AK002, an Anti-Siglec-8 Monoclonal Antibody, in Treatment-Refractory Chronic Urticaria.
37. Management of Chronic Urticaria in a Pediatric Population.
38. Angioedema Due To Acquired C1-Inhibitor Deficiency: Spectrum And Treatment With C1-Inhibitor Concentrate.
39. Forensic DNA phenotyping legislation cannot be based on “Ideal FDP”—A response to Caliebe, Krawczak and Kayser (2017).
40. Omalizumab is effective in symptomatic dermographism—results of a randomized placebo-controlled trial.
41. Omalizumab is effective in cold urticaria—results of a randomized placebo-controlled trial.
42. Effective treatment of therapy-resistant chronic spontaneous urticaria with omalizumab.
43. C1 Inhibitor for Routine Prophylaxis in Patients with Hereditary Angioedema: Interim Results from a European Registry Study.
44. Fully coupled simulation of an opencast mine subjected to earthquake loading.
45. Development and validation of the Urticaria Control Test: A patient-reported outcome instrument for assessing urticaria control.
46. Efficacy of C1-Inhibitor Concentrate (Berinert®) for the Treatment of Cutaneous Attacks of Acute Hereditary Angioedema Compared to Historical Untreated Controls.
47. A theory of porous media for unsaturated soils with immobile air.
48. Influence of the dietary supplement dihydroquercetine on chronic spontaneous urticaria and atopic dermatitis.
49. Prophylaxis with C1 Inhibitor Concentrate before Tooth Extractions in Patients with Hereditary Angioedema.
50. Hereditary Angioedema Due to Missense Mutations in the Factor XII Gene: Clinical Features, Trigger Factors, and Therapy.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.